<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02173743</url>
  </required_header>
  <id_info>
    <org_study_id>NL47402.044.13</org_study_id>
    <secondary_id>ABR 47402</secondary_id>
    <nct_id>NCT02173743</nct_id>
  </id_info>
  <brief_title>Platelet-rich Plasma in Calcific Tendinitis</brief_title>
  <official_title>Calcific Tendinitis of the Rotator Cuff: a Randomized Controlled Trial to the Effects of the Adjuvant Application of Platelet-rich Plasma After Needle Aspiration of Calcific Deposits</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Orthopedisch Centrum Oost Nederland</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Orthopedisch Centrum Oost Nederland</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Needle aspiration of calcific deposits (NACD ) is the treatment of choice for calcific
      tendinitis which does not respond to conservative treatment. NACD is effective in
      approximately 70% of the patients.When NACD is not effective, surgery is often the only
      treatment that remains.Surgery, however, is discouraged by th e Dutch guidelines for
      diagnosing and treating patients with subacromial pain syndrome.Therefore,both patients and
      the doctors treating those patients will benefit from a more effective minimal invasive
      treatment for calcific tendinitis.Injection of platelet-rich plasma (PRP) might, considering
      its positive effect on tissue repair, be a possible solution here.Previous research
      investigating the effects of PRP on other tendinopathies did, however, show controversial
      results. The aim of this double-blind randomized controlled trial is to investigate the
      effect of the adjuvant application of PRP after NACD on pain reduction ,recovery of shoulder
      function, tendon recovery,resorption of calcific deposits, the percentage of patients with
      persistent complaints and quality of life.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>July 2014</start_date>
  <completion_date type="Anticipated">December 2020</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Numeric Rating Scale (NRS) pain</measure>
    <time_frame>6 months post barbotage</time_frame>
    <description>Score to assess the amount of pain</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Constant-Murley Score (CMS)</measure>
    <time_frame>6 weeks, 3 - 6- 12- 25 months post barbatoge</time_frame>
    <description>To assess shoulder function</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of Life (EQ-5D)</measure>
    <time_frame>6 weeks, 3- 6- 12- 24 months post barbotage</time_frame>
    <description>score to assess the quality of life</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Tendon recovery</measure>
    <time_frame>6 weeks, 3-6-12-24 months post barbotage</time_frame>
    <description>to visualize tendon recovery by ultrasound</description>
  </other_outcome>
  <other_outcome>
    <measure>calcifications</measure>
    <time_frame>baseline, 3 + 12 months post barbotage</time_frame>
    <description>size of calcifications (X-ray)</description>
  </other_outcome>
  <other_outcome>
    <measure>plated plasma analysis</measure>
    <time_frame>baseline</time_frame>
    <description>trombocytes analysis of PRP blood</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">80</enrollment>
  <condition>Calcific Tendinitis</condition>
  <arm_group>
    <arm_group_label>PRP group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>PRP during barbotage</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Regular barbotage</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>PRP</intervention_name>
    <description>platelet enriched autologous blood plasma</description>
    <arm_group_label>PRP group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Control</intervention_name>
    <description>Regular barbotage/care as usual</description>
    <arm_group_label>Control group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age &gt; 18 yrs

          -  clinical manifestions of tendinitis calcarea (pain, stifness, lock sensations, muscle
             atrophy)

          -  persistent pain sympoms &gt;6 months

          -  standardized AP x-ray shows calcific deposit of &gt; 5mm &amp; morphologic Type I &amp; II
             deposits (classification of Gärtner en Simons)

          -  ineffective intervention &gt; 2 types of conservative treatment (among which are
             non-steroidal anti-inflammatory drugs, physiotherapy, local anesthesia injection
             and/or corticosteroids, extracorporele shock wave therapy)

          -  indication and referral for barbotage by orthopeadic surgeon

        Exclusion Criteria:

          -  age &gt; 55 years

          -  morphological type III deposits according to classification of Gärtner and Simons) (as
             indicated by standardized x-ray AP)

          -  bigliani type III acromion, and acromial spur of acromioclavicular osteovyt

          -  previous (ineffective) barbotage

          -  the existence of other shoulder related injuries next to calcific tendinitis
             (full-thickness rupture of the rotator cuff, adhesive capsulitis (frozen shoulder),
             arthrosis of the glenohumeral- or acromioclavicalar joint

          -  shoulder joint instability

          -  shoulder injury due to trauma or previous shoulder surgeries

          -  other types of disorders that could negatively influence the outcomes (rheumatic
             arthritis. cervical spine disorders, neurological upper extremity disorders, diabetes
             mellitus, infections, blood disorders, malignity, pregnancy)

          -  known allergic responses to one of the medications applied in the current study
             (lidocaine, bupivacaine, kenacort)

          -  usage of anti-coagulants other than ascal of plavix
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Edwin Ooms, PhD</last_name>
    <role>Study Director</role>
    <affiliation>OCON</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Rianne Huis in 't Veld, PhD</last_name>
    <role>Study Director</role>
    <affiliation>OCON</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Bart Oudelaar, MSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>OCON</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Orthopedisch Centrum Oost Nederland/ZGT</name>
      <address>
        <city>Hengelo</city>
        <state>Overijssel</state>
        <zip>7550 AM</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <link>
    <url>http://www.ocon.nl</url>
    <description>hospital's url</description>
  </link>
  <verification_date>December 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 19, 2014</study_first_submitted>
  <study_first_submitted_qc>June 23, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 25, 2014</study_first_posted>
  <last_update_submitted>December 21, 2017</last_update_submitted>
  <last_update_submitted_qc>December 21, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">December 22, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>plasma, calcific tendinitis, rotator cuff, PRP</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tendinopathy</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

